Immunoprecipitation of whole-cell lysates with an antiserum against SMYD3 or mTOR, followed by immunoblotting, revealed that SMYD3 is a molecular partner of mTOR in CRC cells (Figs. 3A, 4). The gene discussed is MTOR; the disease is colorectal carcinoma.